SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Berger, J. R.
Right arrow Articles by Arendt, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, J. R.
Right arrow Articles by Arendt, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

HIV dementia: the role of the basal ganglia and dopaminergic systems

Joseph R. Berger

Departments of Neurology and Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky

Gabriele Arendt

Department of Neurology, Heinrich Heine University of Duesseldorf, Duesseldorf, Germany

The clinical features of human immunodefiency virus (HIV) dementia exhibit the hallmarks of a subcortical dementia. These features include psychomotor slowing, apathy, bradykinesia and altered posture and gait similar to those observed in advanced Parkinson's disease. The dementia has the hallmarks attributed to subcortical dementia. The exquisite sensitivity of many of these patients to dopamine receptor blockade suggested a profound and, perhaps, selective abnormality of striatal dopaminergic systems. Additional investigations, electrophysiological, pathological, virological, metabolic and radiological studies, indicate that the basal ganglia are a major target of HIV infection. In this review, we describe the evidence for involvement of basal ganglia and, in particular, the dopaminergic systems, in HIV dementia. We also suggest novel therapeutic strategies that may be beneficial in the treatment of this disorder.

Key Words: AIDS • basal ganglia • dementia • dopamine • HIV • Parkinsonism • striatum

Journal of Psychopharmacology, Vol. 14, No. 3, 214-221 (2000)
DOI: 10.1177/026988110001400304


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
M SARAVANAN and I W TURNBULL
Brain: non-infective and non-neoplastic manifestations of HIV
Br. J. Radiol., November 1, 2009; 82(983): 956 - 965.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Maingat, P. Vivithanaporn, Y. Zhu, A. Taylor, G. Baker, K. Pearson, and C. Power
Neurobehavioral Performance in Feline Immunodeficiency Virus Infection: Integrated Analysis of Viral Burden, Neuroinflammation, and Neuronal Injury in Cortex
J. Neurosci., July 1, 2009; 29(26): 8429 - 8437.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Zhu, C. F. Mactutus, D. R. Wallace, and R. M. Booze
HIV-1 Tat Protein-Induced Rapid and Reversible Decrease in [3H]Dopamine Uptake: Dissociation of [3H]Dopamine Uptake and [3H]2{beta}-Carbomethoxy-3-{beta}-(4-fluorophenyl)tropane (WIN 35,428) Binding in Rat Striatal Synaptosomes
J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1071 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Cs. Horvath, G. G. Kovacs, V. Kovari, K. Majtenyi, Y. L. Hurd, and E. Keller
Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age
J. Neurosci., December 5, 2007; 27(49): 13371 - 13375.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. M. B. Castelo, M. G. Courtney, R. J. Melrose, and C. E. Stern
Putamen Hypertrophy in Nondemented Patients With Human Immunodeficiency Virus Infection and Cognitive Compromise
Arch Neurol, September 1, 2007; 64(9): 1275 - 1280.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Fitting, R. M. Booze, and C. F. Mactutus
Neonatal Intrahippocampal Glycoprotein 120 Injection: The Role of Dopaminergic Alterations in Prepulse Inhibition in Adult Rats
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1352 - 1358.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Sui, S. Fan, L. Sniderhan, E. Reisinger, A. Litzburg, G. Schifitto, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar
Inhibition of Mixed Lineage Kinase 3 Prevents HIV-1 Tat-Mediated Neurotoxicity and Monocyte Activation
J. Immunol., July 1, 2006; 177(1): 702 - 711.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Panavas, E. Serviene, J. Brasher, and P. D. Nagy
Yeast genome-wide screen reveals dissimilar sets of host genes affecting replication of RNA viruses
PNAS, May 17, 2005; 102(20): 7326 - 7331.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
H.-J. von Giesen, B. A. Haslinger, S. Rohe, H. Koller, and G. Arendt
HIV Dementia Scale and Psychomotor Slowing--The Best Methods in Screening for Neuro-AIDS
J Neuropsychiatry Clin Neurosci, May 1, 2005; 17(2): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. Paul, T. P. Flanigan, K. Tashima, R. Cohen, J. Lawrence, E. Alt, D. Tate, C. Ritchie, and C. Hinkin
Apathy Correlates With Cognitive Function But Not CD4 Status in Patients With Human Immunodeficiency Virus
J Neuropsychiatry Clin Neurosci, February 1, 2005; 17(1): 114 - 118.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. MORDELET, K. KISSA, A. CRESSANT, F. GRAY, S. OZDEN, C. VIDAL, P. CHARNEAU, and S. GRANON
Histopathological and cognitive defects induced by Nef in the brain
FASEB J, December 1, 2004; 18(15): 1851 - 1861.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
F. Wenserski, H.-J. von Giesen, H.-J. Wittsack, A. Aulich, and G. Arendt
Human Immmunodeficiency Virus 1-associated Minor Motor Disorders: Perfusion-weighted MR Imaging and H MR Spectroscopy
Radiology, July 1, 2003; 228(1): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Boven, N. Vergnolle, S. D. Henry, C. Silva, Y. Imai, J. Holden, K. Warren, M. D. Hollenberg, and C. Power
Up-Regulation of Proteinase-Activated Receptor 1 Expression in Astrocytes During HIV Encephalitis
J. Immunol., March 1, 2003; 170(5): 2638 - 2646.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H.-J. von Giesen, H.-J. Wittsack, F. Wenserski, H. Koller, H. Hefter, and G. Arendt
Basal Ganglia Metabolite Abnormalities in Minor Motor Disorders Associated With Human Immunodeficiency Virus Type 1
Arch Neurol, August 1, 2001; 58(8): 1281 - 1286.
[Abstract] [Full Text] [PDF]



Advertisement